Visualization Technology Increases Productivity for Batch Operations

Honeywell’s Experion Batch provides operators with improved visibility, simplified maintenance, and faster validation.

Honeywell Process Solutions (HPS) introduced a control technology solution that increases productivity for batch operations and speed-to-market of batch products by allowing operators to see an intuitive and comprehensive timeline of every task required to complete a product batch. Honeywell’s Experion Batch uses patent-pending visualization technology to provide batch automation processes with the benefits of distributed control capability. This approach provides operators with insights into upcoming events or potential delays, which make it easier for them to conduct multiple tasks, take appropriate actions sooner, and adjust next steps accordingly. It also makes operations less dependent on individual operator experience, which will help manufacturers overcome skill gaps at a time when more veteran operators are retiring.

Experion Batch is designed for industries including pharmaceuticals, for which manufacturers are challenged to increase operator efficiency and product quality while using fewer resources to reduce costs. The technology simplifies ongoing maintenance by eliminating the need for a centralized, dedicated batch server. This design enables engineering and maintenance personnel to take a unit controller out of service without affecting other units. Experion Batch also allows plants to easily transition from recipe testing to execution while reducing testing and validation efforts, and it is aligned with international batch standards ISA S88 and IEC 61512-1.

Source: Honeywell Process Solutions

Source link

Visualization Tech Boosts Batch Ops

Gellan Gum Market Statistics, Facts, Share, Production Report 2018 – Pharmaceuticals

The Global Gellan Gum Market is expected to grow at a compound annual growth rate of 3.83% over the period 2018 to 2023. The market is expected to reach US$62.960 million by 2023 from a market size of US$50.257 million in 2017.

Ask for Sample PDF of Report @ https://ift.tt/2H3vhR5

Gellan Gum is an ingredient produced by culturing bacteria and helps in improving the quality of the product. Increasing demand of bakery products such as jelly jam, pudding, confectionary and others is the key driver of global gellan gum market. Growing global aging population and increasing demand for cosmetics and personal products is further driving the growth of gellan gum market across the globe. Gellan gum is currently being used as a multifunctional additive in various pharmaceutical products for oral, nasal, ophthalmic, and other applications due to its unique structure and beneficial properties. Thus, growing pharmaceutical industry owing to rising incidence of chronic diseases and growing healthcare industry across the globe will continue to propel the growth of global gellan gum market over the forecast period.

North America holds a significant share in the global market on account of growing applications of gellan gum in food & beverage and pharmaceutical industry in the region. The market in the Asia Pacific is expected to witness a high growth rate over the forecast period due to increasing production of gellan gum in this region.

Research Methodology :-

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segments which have been covered as part of the report.

Market Dynamics :-

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of gellan gum. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.

Market Segmentation

Thirdly, Gellan Gum market has been segmented by type, application, and geography as below:

By Type :-

• Low-Acyl Gellan Gum
• High-Acyl Gellan Gum

By Application:-

• Food and Beverage
• Pharmaceuticals
• Chemical
• Cosmetics
• Others

Make an Enquiry @ https://ift.tt/2qCGsVD

By Geography :-

• Americas
• North America
• South America
• Europe Middle East and Africa
• Europe
• Middle East and Africa
• Asia Pacific
• Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others.

 Key industry players profiled as part of this report are ;

• DSM,
• Biopolymer International,
• Xinjiang Fufeng Biotechnologies,
• Hawkins Watts,
• CP Kelco,
• Hangzhou Gellan Solutions

Browse Full Report @ https://ift.tt/2H2Qz13

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Source link

Amgen chooses Rhode Island for its new next generation biomanufacturing plant | Pharmaceutical

Biotechnology company Amgen has announced its plans to develop a new, next generation biomanufacturing plant at its campus in West Greenwich, Rhode Island. It will the first of its kind in the US and utilise next-generation biomanufacturing capabilities and manufacture products for the US and global markets.

Since 2004, the company Foundation has also committed over $4.8mn to support science education and community programs in Rhode Island.

The plant will incorporate multiple innovative technologies into a single facility, and will be built in half the construction time, with approximately one half of the operating cost of a traditional plant.

Next-generation biomanufacturing plants require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions.

The new plant will also utilise “disposable plastic containers, instead of the steel vats of a traditional plant, to grow cells, eliminating the need for complicated piping and wiring, making it easier to change product lines,” Reuters has reported.

“Amgen has three decades of experience in biologics manufacturing, and we are proud of our track record of providing a reliable supply of high-quality medicines for patients around the world,” explained Esteban Santos, Executive Vice President of Operations at Amgen.

See also

“We are pleased to build the first commercial scale, next-generation biomanufacturing plant in the US, leveraging Amgen’s capabilities and incorporating the latest technologies.”

Upon completion, the new biomanufacturing plant will create approximately 150 additional highly-skilled manufacturing positions and approximately 200 construction and validation jobs.

“I am thrilled that Amgen is planning to expand and bring new, highly skilled jobs to Rhode Island and further enhance the State’s life sciences community and manufacturing expertise,” said Rhode Island Governor Gina Raimondo. “We welcome Amgen’s future health care advancements for patients around the world that will come from this new biomanufacturing plant.”

Amgen opened its first next-generation biomanufacturing plant in Singapore in 2014. Within the plant, the equipment is portable, smaller and disposable, which provides greater flexibility and speed when manufacturing different medicines simultaneously.

This process eliminates costly and complex retrofitting inherent in standard facilities which allows Amgen to respond to changing demands with increased agility, ultimately impacting the speed at which a medicine is available for patients.

Amgen has invested more than $1.5bn in its Rhode Island site, adding more than 500,000 square feet of manufacturing, utility, administrative and laboratory space to the campus. There are also 625 full-time staff members employed at the campus.

Source link

Global Pharmaceutical Warehousing Market Growth Analysis in Next Four Years

WiseGuyReports has announced the addition of a new intelligence report, titled “Global Pharmaceutical Warehousing Market – Forecasts from 2017 to 2022”.

The global pharmaceutical warehousing market was valued at US$53.006 billion in 2017 and is expected to grow at a CAGR of 5.14% to reach a market size of US$68.107 billion by the year 2022. Warehouse management systems can be deployed by specialized, knowledgeable companies so as to ensure all the benefits and potential savings. Pharmaceutical companies have automated solutions in order to tackle quality and operational challenges without the need for human contact. Such systems for warehouse can optimize the storage space utilisation, improve productivity of processes, decrease operating costs and maintain a strategic competitive edge for stocking of inventory.

Market Outlook

Factors like rapid urbanization, government regulations, and technological advancements have led to the shift of pharmaceuticals industry from unorganized to organized sector while driving the pharmaceutical warehousing market. Moreover, the rising awareness and concern about health coupled with increasing number of diseases propel the demand for pharmaceuticals products while augmenting the pharmaceuticals warehousing market growth. The ongoing product innovation and development of energy efficient warehousing enhance the opportunities for the market to grow over the projected period. However, the high initial cost involved in setting up the infrastructure do hamper the market growth.

Geographic Outlook

Geographically, EMEA region is expected to drive the global market of pharmaceutical warehousing owing to the expanding pharmaceutical industry in the region coupled with growing demand for organized pharmaceutical retailing. Asia Pacific region is also expected to contribute to the global growth on account of rapid modernisation, growing number of diseases and availability of quality medicines.

Research Methodology

Firstly, the report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next, the section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of Pharmaceutical Warehousing. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Request Sample Report at https://ift.tt/2H2LJRB

Segmentation

Thirdly, Pharmaceutical Warehousing Market has been segmented on the basis of type of service and geography as follows:

By Type of Service

Cold chain warehouse

Non-cold chain warehouse

By Geography

Americas

North America

South America

Europe Middle East and Africa

Europe

Middle East and Africa

Asia Pacific

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Agility, DHL Supply Chain, DB Schenker, Penske Logistics, UPS, XPO Logistics, KUEHNE + NAGEL, and DSC Logistics.

Table of Content

1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Global Pharmaceutical Warehousing Market Forecast by Type of Service (US$ billion)
6. Global Pharmaceutical Warehousing Market Forecast by Geography (US$ billion)
7. Competitive Intelligence
8. Company Profiles

8.1. Agility

8.2. DHL Supply Chain

8.3. DB Schenker

8.4. Penske Logistics

8.5. UPS

8.6. XPO Logistics

8.7. KUEHNE + NAGEL

8.8. DSC Logistics

 

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

 

Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +1-646-845-9349 (US)                          

Ph: +44 208 133 9349 (UK)        

 

Source link

HCS Software and Services Market to Expand at a CAGR of 6.9% by 2022 – Pharmaceuticals

The global high content screening (HCS) software and services market is foretold to welcome a bolstering demand owing to the augmented prominence of the secondary screening of cells for toxicity studies. Research and educational institutions could help the market gain a strong traction in the coming years. HCS instrument manufacturers are expected to receive a wealth of opportunities created with the establishment of automated systems for cell scalability and separation analysis. Furthermore, the fortifying growth of the HCS technology in view of the soaring demand for vastly efficient therapeutic cell purification protocols could augur well for the market.

According to the analysis of Transparency Market Research (TMR), the global HCS software and services market is predicted to reach a revenue valuation of approximately US$1.1 bn by the end of 2022, progressing from a valuation of around US$0.8 bn achieved in 2017. During the forecast period 2017–2022, the market could rise at a 6.9% CAGR.

Global HCS Software and Services Market: Major Insights

The sales of HCS instruments are prognosticated to be boosted with the towering demand for novel cell analysis technologies due to enlarging drug discovery processes and improved toxicity studies. The demand in the world HCS software and services market could be increased by the development of solutions offering significant sensitivity in determining problems as serious as hepatotoxicity. This could be on account of the rising significance of the risk assessment of severe diseases for drug discovery across a range of biotechnology and pharmaceutical companies.

Request for Sample Copy of Report @ https://ift.tt/2mdXrfJ

Although the high cost of HCS instruments could negatively impact growth, their growing demand for providing comprehensive offerings to lab services is foreseen to help the world HCS software and services market achieve a healthy comeback.

The world HCS software and services market is projected to be segregated as per product type classification into two segments, i.e. HCS services and HCS software. According to the publication, the HCS services market could exhibit dominance with its superior valuation of close to a US$0.8 bn anticipated to be attained by 2022. The market could also be dependent on industry segments such as bio, educational institutions, government organizations, independent contract research organizations (CROs), and pharmaceutical and healthcare. As per application, the market is forecasted to be categorized into toxicity studies, target identification and validation, primary and secondary screening, and compound profiling.

By region, players operating in the world HCS software and services market could find opportunities prevailing in North America, the Middle East and Africa (MEA), Latin America, Europe, and Asia Pacific except Japan (APEJ) and Japan. With a 7.5% CAGR prophesied to be posted during the course of the forecast period, North America is envisaged to register a dominating share in the market on the basis of revenue.

Enquiry for discount on this report @ https://ift.tt/2JPCu4L

Global HCS Software and Services Market: Vendor Landscape

Among the leading companies, Thermo Fisher Scientific, Inc., General Electric Company, Becton, Dickinson & Company, PerkinElmer, Inc., Yokogawa Electric Corporation, Olympus Corporation, Merck & Co., Inc., Thorlabs, Inc., Sysmex Corporation, and Danaher Corporation are envisioned to showcase their prominence in the worldwide HCS software and services market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://ift.tt/16ogAvy

Source link